Analyst Report Update SP Global Inc Market Position and Segment Outlook TJX Companies Seen as Top Dividend Growth Stock Analyst Upgrades Price Target Traders See Rising Odds of Fed Rate Hike by Mid2027 Prediction Markets Signal Fed Minutes Reveal Policymakers Anticipate Potential Rate Hikes if Inflation Persists Amid Geopolitical Risks Tesla Expands Full SelfDriving Supervised to China as Domestic EV Rivals Accelerate Autonomous Tech Berkshire Hathaway Revamps Portfolio With Major Stakes in Delta Air Lines and Alphabet PNNT Q1 2026 Earnings Earnings Miss Amid Stable Portfolio Performance VNRX Q1 2026 Earnings EPS Misses Estimates Stock Surges on Strategic Progress MPLT Q1 2026 Earnings EPS Miss of 20 Amid No Revenue Stock Declines i80 Gold Corp IAUX Q1 2026 Earnings Surprise EPS Beat as Loss Narrows LEGN Q1 2026 Earnings EPS Falls Short of Estimates Yet Stock Advances on Operational Progress Rigetti Computing Inc RGTI Q1 2026 Earnings NarrowerThanExpected Loss as Quantum Computing Firm Prepares for Commercial Scale Dynamix Corporation ETHM Holds Steady at 1077 as Market Awaits Catalyst Terns Pharmaceuticals TERN Holds Steady Near Support as Biotech Sector Watches for Catalysts Shattuck Labs STTK Holds Steady at 61 Testing Familiar Support Levels Keurig Dr Pepper KDP Shares Edge Higher as Beverage Giant Holds Near Key Support Ashford Hospitality Trust AHT Gains 295 as Hospitality Sector Shows Resilience RY Q1 2026 Earnings Narrow EPS Beat Fails to Lift Stock Origin Agritech Limited SEED Q4 2011 Earnings EPS Surges Past Expectations Despite Missing Revenue Details Tecogen Q1 2026 Earnings NarrowerThanExpected Loss Lifts Shares WiMi Hologram Cloud Inc Q4 2020 Earnings Slight EPS Miss Amidst Revenue Disclosure Absence GLDG Q1 2026 Earnings Narrowerthanexpected loss as exploration ramp continues APAM Q1 2026 Earnings EPS Miss Highlights Margin Pressure Despite Steady AUM Growth Mutual Fund Returns Show Mixed Trends Amid Market Volatility IBKR Q1 2026 Earnings Earnings Miss Expectations Amid Volatile Markets Enliven Therapeutics ELVN Slips 19 as Stock Tests Key Support Near 3858